文献速递关节外科

全髋关节置换术后3个月内关节内注射糖皮质激素感染风险增加的Meta分析:基于膝与髋关节置换术的研究

Infection Risk Increases After Total Hip Arthroplasty Within 3 Months Following Intra-Articular Corticosteroid Injection. A Meta-Analysis on Knee and Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2022-12-30

该系统综述与Meta分析检索截至2022年1月4日的文献,纳入28项研究共480,532例患者,评估术前关节内糖皮质激素注射与关节置换术后感染风险的关系。结果显示,全髋关节置换术(THA)患者中注射与假体周围感染(PJI)显著相关(OR 1.55,P=0.001,95%CI 1.357-1.772),而膝关节置换术未见关联;THA患者术前3个月内注射时PJI风险统计学升高(OR 1.20,P=0.045,95%CI 1.058-1.347)。作者结论认为THA术前接受注射者PJI风险更高,建议术者避免在髋关节置换前3个月内进行糖皮质激素注射。

要点

  • THA患者术前关节内糖皮质激素注射与PJI显著相关(OR 1.55,P=0.001,95%CI 1.357-1.772)。
  • 膝关节置换术患者中注射与PJI未见关联。
  • THA患者术前3个月内注射时PJI风险统计学升高(OR 1.20,P=0.045,95%CI 1.058-1.347)。

核心结论

  • 接受THA且术前曾行关节内糖皮质激素注射的患者,发生PJI的风险统计学升高。
  • 全膝关节置换术患者中未见糖皮质激素注射与PJI的关联。
  • 注射时机很重要:作者建议术者避免在髋关节置换前3个月内进行糖皮质激素注射,因为与等待3个月间隔相比似乎更不安全。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Web of Science和Cochrane Library截至2022年1月4日。
  • 从4,596项研究中筛选28项研究、共480,532例患者进行定性分析。
  • 纳入描述关节置换(髋、膝)术前接受糖皮质激素注射患者的研究;对聚焦糖皮质激素注射与PJI的研究进行Meta分析。
  • 偏倚风险与证据质量评估基于「Downs and Black's Checklist for Measuring Quality」。

主要发现

  • THA患者中,PJI与糖皮质激素注射之间存在显著关联(OR 1.55,P=0.001,95%CI 1.357-1.772)。
  • 膝关节置换术患者中,未发现糖皮质激素注射与PJI的关联。
  • THA患者若术前3个月内进行注射,PJI风险统计学升高(OR 1.20,P=0.045,95%CI 1.058-1.347)。

临床怎么用

  • 作者建议术者避免在髋关节置换前3个月内进行糖皮质激素注射,因为与等待3个月间隔相比似乎更不安全。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Much debate continues regarding the risk of postoperative infection after intra-articular corticosteroid injection prior to total joint arthroplasty. The aim of this study was to evaluate the risk of periprosthetic joint infection (PJI) or other complications after joint arthroplasty in patients who received preoperative corticosteroids injections. METHODS: A literature search was performed on PubMed, Web of Science, and Cochrane Library through January 4, 2022. Of 4,596 studies, 28 studies on 480,532 patients were selected for qualitative analysis. Studies describing patients receiving corticosteroids injections before joint arthroplasty (hip, knee) were included in the systematic review. A meta-analysis was performed of studies focusing on corticosteroids injections and PJI. Assessment of risk of bias and quality of evidence was based on the "Downs and Black's Checklist for Measuring Quality". RESULTS: A significant association (odds ratio: 1.55, P = .001, 95% confidence interval: 1.357-1.772) between PJI and corticosteroids injections was found for total hip arthroplasty (THA). No association was found for knee arthroplasty procedures. The risk of PJI is statistically higher (odds ratio: 1.20, P = .045, 95% confidence interval: 1.058-1.347) if the injections are performed within 3 months preoperatively in THA patients. CONCLUSION: Patients undergoing THA who previously received intra-articular injections of corticosteroids may expect a statistically higher risk of developing PJI. On the contrary, no association between corticosteroids injections and PJI could be seen in total knee arthroplasty patients. In addition, injection timing plays an important role: surgeons should refrain from administering corticosteroids injections within 3 months before hip arthroplasty, as it appears to be less safe than waiting a 3-month interval.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Albanese J, Feltri P, Boffa A, et al. Infection Risk Increases After Total Hip Arthroplasty Within 3 Months Following Intra-Articular Corticosteroid Injection. A Meta-Analysis on Knee and Hip Arthroplasty. J Arthroplasty. 2022. PMID: 36592824. doi:10.1016/j.arth.2022.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。